SENSEX NIFTY
Marksans Pharma Quarterly Results, Marksans Pharma Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Marksans Pharma
Marksans Pharma
BSE: 524404|NSE: MARKSANS|ISIN: INE750C01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 10, 16:30
56.00
2.95 (5.56%)
VOLUME 549,318
LIVE
NSE
Dec 10, 16:30
56.00
2.95 (5.56%)
VOLUME 1,608,229
Download Annual Report PDF Format 2014 | 2013 | 2012 | 2011 | 2010

Quarterly Results of Marksans Pharma

------------------- in Rs. Cr. -------------------
Sep '14 Jun '14 Mar '14 Dec '13 Sep '13
Net Sales/Income from operations 107.55 100.67 83.67 80.74 78.51
Other Operating Income -- -- 0.61 -- --
Total Income From Operations 107.55 100.67 84.28 80.74 78.51
EXPENDITURE
Consumption of Raw Materials 46.63 44.89 48.30 37.24 32.46
Purchase of Traded Goods 6.74 8.41 6.73 7.55 6.74
Increase/Decrease in Stocks 5.90 2.45 -1.42 -1.53 -0.45
Power & Fuel -- -- -- -- --
Employees Cost 5.46 5.82 7.12 4.80 4.78
Depreciation 2.16 2.24 1.96 2.25 2.24
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 10.24 9.29 9.96 10.58 10.48
P/L Before Other Inc. , Int., Excpt. Items & Tax 30.44 27.56 11.61 19.85 22.27
Other Income -- -- -- -- --
P/L Before Int., Excpt. Items & Tax 30.44 27.56 11.61 19.85 22.27
Interest 3.74 2.54 3.47 1.67 2.54
P/L Before Exceptional Items & Tax 26.69 25.02 8.14 18.18 19.73
Exceptional Items -- -- -- -- --
P/L Before Tax 26.69 25.02 8.14 18.18 19.73
Tax 6.67 6.75 2.85 2.50 1.93
P/L After Tax from Ordinary Activities 20.02 18.26 5.29 15.68 17.80
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 20.02 18.26 5.29 15.68 17.80
Equity Share Capital 38.53 38.53 38.53 38.53 38.53
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 0.52 0.47 0.14 0.41 0.46
Diluted EPS 0.52 0.47 0.14 0.41 0.46
EPS After Extra Ordinary
Basic EPS 0.52 0.47 0.14 0.41 0.46
Diluted EPS 0.52 0.47 0.14 0.41 0.46
Public Share Holding
No Of Shares (Crores) 18.78 18.78 18.78 18.78 18.78
Share Holding (%) 48.75 48.75 48.75 48.75 48.75
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 19.75 19.75 19.75 19.75 19.75
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) 51.25 51.25 51.25 51.25 51.25
Notes
Source : Dion Global Solutions Limited
Quick Links for marksanspharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.